Exome sequencing identifies GRIN2A as frequently mutated in melanoma. - Wikidata - awgldk - TriplyDB

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

http://www.wikidata.org/entity/Q35179796

about

The spectrum of SWI/SNF mutations, ubiquitous in human cancers Human genetics and genomics a decade after the release of the draft sequence of the human genome Melanoma: from melanocyte to genetic alterations and clinical options A form of the metabolic syndrome associated with mutations in DYRK1B NCG 4.0: the network of cancer genes in the era of massive mutational screenings of cancer genomes A landscape of driver mutations in melanoma Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma Melanoma genome sequencing reveals frequent PREX2 mutations A novel computational biostatistics approach implies impaired dephosphorylation of growth factor receptors as associated with severity of autism.Network of Cancer Genes (NCG 3.0): integration and analysis of genetic and network properties of cancer genes VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing Systems Biology Approach for Cancer Vaccine Development and Evaluation High-throughput sequencing for biology and medicine New developments in dermatological oncogenetics Pathways and therapeutic targets in melanoma Shedding light on melanocyte pathobiology in vivo Melanoma: from mutations to medicine Type II p21-activated kinases (PAKs) are regulated by an autoinhibitory pseudosubstrate Substrate and Inhibitor Specificity of the Type II p21-Activated Kinase, PAK6 The structure and substrate specificity of human Cdk12/Cyclin K Cancer genome sequencing: understanding malignancy as a disease of the genome, its conformation, and its evolution.BRAF(L597) mutations in melanoma are associated with sensitivity to MEK inhibitors TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.Signaling, Regulation, and Specificity of the Type II p21-activated Kinases Exome sequencing identifies frequent mutation of ARID1A in molecular subtypes of gastric cancer Inhibitors of the anaplastic lymphoma kinase Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders Inactivating CUX1 mutations promote tumorigenesis Identification of somatic mutations in EGFR/KRAS/ALK-negative lung adenocarcinoma in never-smokers Somatic mutations in MAP3K5 attenuate its proapoptotic function in melanoma through increased binding to thioredoxin Host modulators of H1N1 cytopathogenicity Guanine holes are prominent targets for mutation in cancer and inherited disease Clonal architectures and driver mutations in metastatic melanomas Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes Computational Identification of Novel Stage-Specific Biomarkers in Colorectal Cancer Progression Genome-scale sequencing to identify genes involved in Mendelian disorders Genetic basis for clinical response to CTLA-4 blockade in melanoma Impact of the next-generation sequencing data depth on various biological result inferences.A practical method to detect SNVs and indels from whole genome and exome sequencing data.

P2860

Q21090801-F0350AF7-72F8-4292-98AF-CD2B392E5A47 Q21245451-A67E36BD-832A-4196-8FDD-217BC03F02D8 Q21284811-79BE6464-5C53-4F30-9552-20ED6382D4EE Q24297819-CE05998C-CF8C-45C8-9735-76D5A2F09D4A Q24596715-97392220-8D79-4404-B9CA-A363D65E95AE Q24603357-44C5E063-9182-4CC9-A59C-1A4CEBD098BC Q24607661-59E6DA49-75C9-410A-931C-CFF368B30ACB Q24610463-5E7E0548-70BD-4D5C-B07D-3830FB783AFE Q24612710-BD72B63B-2869-41DE-90C1-919F4669EA33 Q24619351-7D4FF05E-437B-4EDF-AFB5-D17F96FF22D6 Q24628978-52968E56-947A-421E-A6F3-21627A8E8FF0 Q26782580-B7EB1B95-FD9F-4A30-BCDC-EEC76C01C51B Q26823498-856ACF8C-D95D-4901-A277-3468C9D00794 Q26853582-3A128D8E-985D-4146-839B-F923DB3DD394 Q26865736-1B139AB6-2626-4E43-8316-34FA0A471FAF Q26866190-EC633984-845A-4454-B95C-3646BD42D135 Q27024061-6714449F-A4EC-41AB-8414-96F39E6D18BF Q27673339-F40CBD45-F261-4154-96FC-05C63FCF50F8 Q27680556-598CDA0A-1DFA-43A6-90A8-083B3F33C6F6 Q27682428-BB712366-9F7B-4662-989D-5E26AB3BF9A3 Q27690285-66201AAA-AE42-46E1-9B21-4D5F8A9317CA Q27851843-3B421021-27C0-4BB9-A768-3875BF6C0BE8 Q27853068-3AD086A6-2F75-484D-A594-A3BDEA61A6FE Q28083745-8B264397-D4A4-4F0D-8B0E-0C51942728B3 Q28251814-291796C8-829E-41B3-99E1-41D5358BCA45 Q28267124-041A90F0-E68C-4CE3-9ED4-4F3F6C4E5A18 Q28275103-82484276-9E3A-4E29-B953-24837DCA31C8 Q28279421-1B59DC73-82DB-428F-A3CB-EF3446EBF4DC Q28303563-A08683A3-88F8-4C52-9080-888A722A7AA4 Q28383535-B1C326FA-30E7-4B85-B670-5D3EE292A33F Q28397328-71619627-67EC-492F-975D-4981AC281386 Q28481798-A82E7C89-8015-4CA5-813D-88999B21899F Q28533852-F34D360C-000D-4CFC-AC45-4F80CCC661A6 Q28544919-7BF26EB4-CB27-4F85-966A-0E87439D3997 Q28546038-6482418F-50B4-4C31-A53D-9EA9D0901EC6 Q28552533-96149669-7CF1-436A-98C0-E8F2133060DB Q28657569-277E2225-2B58-4C13-82C2-C928A93D3309 Q29620594-95169971-92AB-4FFC-A698-05880C8F1EE4 Q30587393-2D5882AC-D139-4FAE-9939-12AFE95CDE04 Q30653786-B81400EE-9553-4F9E-BE1C-886E1A077254

P2860

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

http://www.wikidata.org/entity/Q35179796

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@ast

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@en

type

label

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@ast

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@en

prefLabel

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@ast

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@en

P1433

Q35179796-DDDDA748-DA2D-449A-A736-72400C6F7B32

P1476

Q35179796-5A05DC5E-1197-4A3B-856F-DD9E9353D14A

P2093

Q35179796-335781F7-7267-408F-9AF6-D64D3B5B8772

Q35179796-3DBB3FDF-8232-41A1-983A-374DDF9BCD96

Q35179796-43327C41-584E-4209-938A-DD7093D4E08E

Q35179796-51D9D080-AD51-4834-907A-F3511073C162

Q35179796-7F00E26D-FC88-4D74-A52C-3A0E1BE35E1D

Q35179796-A80C15B6-329D-4E35-9389-59079B322E0B

Q35179796-AFA3AAAF-9AE6-4939-BD48-9275677C69FA

Q35179796-C73FE863-39DA-4885-8693-4A339D85995E

Q35179796-C768EDD9-0578-4A3F-BA24-65F025DCA75D

Q35179796-D5B4A254-0504-42CA-9A8F-93085A63F72E

P2860

Q35179796-0064F316-20FC-4609-A29F-4F537AECF696

Q35179796-0DC1D6C8-71B9-455F-B166-26A8449D1BC2

Q35179796-14688FB4-71FF-404B-93B5-2641AB3C0E8E

Q35179796-1926CD8D-16C1-4646-9C27-A8D76BDA9AEE

Q35179796-2267125A-EEBE-46A0-8D96-7C8544735DF6

Q35179796-387CCBDD-0AC5-4F16-9873-38071003157A

Q35179796-3F24CC84-BE9C-45FE-AEFE-9D2B0DF550CB

Q35179796-4072AC88-D3D9-4061-B8B3-42F793E279D1

Q35179796-42053AD9-E1E7-4E1A-AF39-A3E8A6C32131

Q35179796-44637930-0D38-4B80-A31C-B216826610A7

P2888

Q35179796-6E128D23-EABC-4FF4-A0AC-0860B534EBC8

P304

Q35179796-6CCB3FD1-75B5-4271-8A07-48D2600606BF

P31

Q35179796-62972413-DE11-460B-BE1C-518DD5E78150

P356

Q35179796-E6F4EEAB-D381-4F00-BA8B-FFDCD417C373

P407

Q35179796-5291F577-CB31-49F2-9167-795895DE5E38

P433

Q35179796-A27EC3C1-29A6-4137-8E8F-83DE8B2A6EFE

P478

Q35179796-2D54BC44-C723-4BEE-A69B-5B31856A8E4D

P50

Q35179796-04B77C11-9F44-4C33-9A1C-AD128A34AC02

Q35179796-3098C4C6-F529-4DA0-935C-07290EBB82F0

Q35179796-3B1DD70A-8A21-4A45-828F-FC1B3A244C9F

Q35179796-DAA651CF-88CA-480E-945E-7ABE25DCF97A

P577

Q35179796-EE8E813F-69E8-448D-BDD6-678F3E9F8AF0

P5875

Q35179796-73FD34AB-F64D-4626-A7F6-005A854A90EF

P6179

Q35179796-D91A480D-3739-4F08-A73E-9D17954A0D77

P698

Q35179796-E329D586-30F5-4484-BA3B-FA8180BD1610

P932

Q35179796-D0760C72-A7B1-4CB3-912C-3F6C4D1F984E

P356

P1433

Nature Genetics

P1476

Exome sequencing identifies GRIN2A as frequently mutated in melanoma.

@en

P2093

Jamie K Teer

http://www.w3.org/2001/XMLSchema#string

Jared Gartner

http://www.w3.org/2001/XMLSchema#string

Jeffrey E Gershenwald

http://www.w3.org/2001/XMLSchema#string

Jimmy C Lin

http://www.w3.org/2001/XMLSchema#string

Michael A Davies

http://www.w3.org/2001/XMLSchema#string

Steven A Rosenberg

http://www.w3.org/2001/XMLSchema#string

Steven Robinson

http://www.w3.org/2001/XMLSchema#string

Todd D Prickett

http://www.w3.org/2001/XMLSchema#string

Vijay Walia

http://www.w3.org/2001/XMLSchema#string

William Robinson

http://www.w3.org/2001/XMLSchema#string

P2860

The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins

A comprehensive catalogue of somatic mutations from a human cancer genome

Analysis of the tyrosine kinome in melanoma reveals recurrent mutations in ERBB4.

Cancer statistics, 2010

Mutations of the BRAF gene in human cancer

The consensus coding sequences of human breast and colorectal cancers

High frequency of mutations of the PIK3CA gene in human cancers

EphB receptors interact with NMDA receptors and regulate excitatory synapse formation

Cancer genes and the pathways they control

Disruption of Trrap causes early embryonic lethality and defects in cell cycle progression

P2888

P304

442-446

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NG.810

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

43

http://www.w3.org/2001/XMLSchema#string

P50

Katherine Stemke-Hale

Yardena Samuels

NISC Comparative Sequencing Program

P577

2011-04-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51057096

http://www.w3.org/2001/XMLSchema#string

P6179

1032031050

http://www.w3.org/2001/XMLSchema#string

P698

21499247

http://www.w3.org/2001/XMLSchema#string

P932

3161250

http://www.w3.org/2001/XMLSchema#string